Isolation and characterisation of Ebolavirus-specific recombinant antibody fragments from murine and shark immune libraries

Molecular Immunology

Volumn 48, Issue 15-16, 2011, Pages 2027-2037

  Goodchild, Sarah A ^a   Dooley, Helen ^b   Schoepp, Randal J ^c   Flajnik, Martin ^b   Lonsdale, Stephen G ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

Bio panning; Ebolavirus; IgNAR; Nurse shark; ScFv

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PROTEIN VP40; RECOMBINANT ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; VIRUS NUCLEOPROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BUNDIBUGYO EBOLAVIRUS; CONTROLLED STUDY; COTE D'IVOIRE EBOLAVIRUS; CROSS REACTION; EBOLA VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNITY; MALE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN BINDING; RESTON EBOLAVIRUS; SENSITIVITY AND SPECIFICITY; SHARK; SUDAN EBOLAVIRUS; VIRUS ISOLATION; WESTERN BLOTTING; ZAIRE EBOLAVIRUS;

ANIMALS; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; EBOLAVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN FRAGMENTS; MICE; PEPTIDE LIBRARY; PROTEIN DENATURATION; RECOMBINANT PROTEINS; SHARKS; VIRAL PROTEINS;

CHONDRICHTHYES; COTE D'IVOIRE EBOLAVIRUS; EBOLA VIRUS; GINGLYMOSTOMA CIRRATUM; GINGLYMOSTOMATIDAE; MURINAE; PRIMATES; RESTON EBOLAVIRUS; SUDAN EBOLAVIRUS; ZAIRE EBOLAVIRUS;

EID: 80051927541     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2011.06.437     Document Type: Article

References (68)

1. Alibek K. Biohazard 2000, Arrow, London.
2. Borio L., Inglesby T., Peters C.J., Schmaljohn A.L., Hughes J.M., Jahrling P.B., Ksiazek T., Johnson K.M., Meyerhoff A., O'Toole T., Ascher M.S., Bartlett J., Breman J.G., Eitzen E.M., Hamburg M., Hauer J., Henderson D.A., Johnson R.T., Kwik G., Layton M., Lillibridge S., Nabel G.J., Osterholm M.T., Perl T.M., Russell P., Tonat K. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 2002, 287:2391-2405.
3. Borisevich I.V., Mikhailov V.V., Krasnianskii V.P., Gradoboev V.N., Lebedinskaia E.V., Potryvaeva N.V., Timan'kova G.D. Development and study of the properties of immunoglobulin against Ebola fever. Vopr. Virusol. 1995, 40:270-273.
4. Borisevich I.V., Mikhailov V.V., Potryvaeva N.V., Malinkin Iu N., Kirillov A.P., Krasnianskii V.P., Markov V.I., Makhlai A.A., Lebedinskaia E.V. [Development of the immunoenzyme test-system for detection of Ebola virus antigen]. Vopr. Virusol. 1996, 41:232-234.
5. Broussard L.A. Biological agents: weapons of warfare and bioterrorism. Mol. Diagn. 2001, 6:323-333.
6. Burmester J., Pluckthun A. Construction of scFv fragments from hybridoma or spleen cells by PCR assembly. Antibody Engineering 2001, 19-40. Springer, Heidelberg. first ed. S. Dubel (Ed.).
7. CDC Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup. MMWR Recomm. Rep. 49 2000, 1-14.
8. Chepurnov A.A., Merzlikin N.V., Chepurnova T.S., Vorob'eva M.S. Preparation of rabbit antiserum to Ebola virus. Vopr. Virusol. 1994, 39:286-288.
9. Clem L.W., De Boutard F. Studies on elasmobranch immunoglobulins. Sharks, Skates, and Rays 1967, 581-591. The Johns Hopkins Press, Baltimore, MD. P.W. Gilbert, R.F. Mathewson, D.P. Rall (Eds.).
10. De Genst E., Saerens D., Muyldermans S., Conrath K. Antibody repertoire development in camelids. Dev. Comp. Immunol. 2006, 30:187-198.
11. Diaz M., Greenberg A.S., Flajnik M.F. Somatic hypermutation of the new antigen receptor gene (NAR) in the nurse shark does not generate the repertoire: possible role in antigen-driven reactions in the absence of germinal centers. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:14343-14348.
12. Diaz M., Stanfield R.L., Greenberg A.S., Flajnik M.F. Structural analysis, selection, and ontogeny of the shark new antigen receptor (IgNAR): identification of a new locus preferentially expressed in early development. Immunogenetics 2002, 54:501-512.
13. Dooley H., Flajnik M. Antibody repertoire development in cartilaginous fish. Dev. Comp. Immunol. 2006, 30:43-56.
14. Dooley H., Flajnik M.F., Porter A.J. Selection and characterization of naturally occurring single-domain (IgNAR) antibody fragments from immunized sharks by phage display. Mol. Immunol. 2003, 40:25-33.
15. Dooley H., Grant S.D., Harris W.J., Porter A.J. Stabilization of antibody fragments in adverse environments. Biotechnol. Appl. Biochem. 1998, 28:77-83.
16. Dooley H., Stanfield R.L., Brady R.A., Flajnik M.F. First molecular and biochemical analysis of in vivo affinity maturation in an ectothermic vertebrate. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:1846-1851.
17. Druar C., Saini S.S., Cossitt M.A., Yu F., Qiu X., Geisbert T.W., Jones S., Jahrling P.B., Stewart D.I., Wiersma E.J. Analysis of the expressed heavy chain variable-region genes of Macaca fascicularis and isolation of monoclonal antibodies specific for the Ebola virus' soluble glycoprotein. Immunogenetics 2005, 57:730-738.
18. Dumoulin M., Conrath K., Van Meirhaeghe A., Meersman F., Heremans K., Frenken L.G., Muyldermans S., Wyns L., Matagne A. Single-domain antibody fragments with high conformational stability. Protein Sci. 2002, 11:500-515.
19. Elliott L.H., Sanchez A., Holloway B.P., Kiley M.P., McCormick J.B. Ebola protein analyses for the determination of genetic organization. Arch. Virol. 1993, 133:423-436.
20. Ellis D.S., Stamford S., Lloyd G., Bowen E.T.W., Platt G.S., Way H., Simpson D.I.H. Ebola and Marburg viruses. I. Some ultrastructural differences between strains when grown in vero cells. J. Med. Virol. 1979, 4:201-211.
21. Frommel D., Litman G.W., Finstad J., Good R.A. The evolution of the immune response. XI. The immunoglobulins of the horned shark, Heterodontus francisci: purification, characterisation and structural requirement for antibody activity. J. Immunol. 1971, 106:1234-1243.
22. Geisbert T.W., Hensley L.E., Larsen T., Young H.A., Reed D.S., Geisbert J.B., Scott D.P., Kagan E., Jahrling P.B., Davis K.J. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques. Am. J. Pathol. 2003, 163:2347-2370.
23. Geisbert T.W., Jahrling P.B. Differentiation of Filoviruses by electronmicroscopy. Virus Res. 1995, 39:129-150.
24. Geisbert T.W., Rhoderick J.B., Jahrling P.B. Rapid identification of Ebola virus and related filoviruses in fluid specimens using indirect immunoelectron microscopy. J. Clin. Pathol. 1991, 44:521-522.
25. Georges-Courbot M.C., Lu C.Y., Lansoud-Soukate J., Leroy E., Baize S. Isolation and partial molecular characterisation of a strain of Ebola virus during a recent epidemic of viral haemorrhagic fever in Gabon. Lancet 1997, 349:181.
26. Glockshuber R., Malia M., Pfitzinger I., Pluckthun A. A comparison of strategies to stabilize immunoglobulin Fv-fragments. Biochemistry 1990, 29:1362-1367.
27. Greenberg A.S., Avila D., Hughes M., Hughes A., McKinney E.C., Flajnik M.F. A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks. Nature 1995, 374:168-173.
28. Groen J., van den Hoogen B.G., Burghoorn-Maas C.P., Fooks A.R., Burton J., Clegg C.J., Zeller H., Osterhaus A.D. Serological reactivity of baculovirus-expressed Ebola virus VP35 and nucleoproteins. Microbes Infect. 2003, 5:379-385.
29. Grolla A., Lucht A., Dick D., Strong J.E., Feldmann H. Laboratory diagnosis of Ebola and Marburg hemorrhagic fever. Bull. Soc. Pathol. Exot. 2005, 98:205-209.
30. Hamers-Casterman C., Atarhouch T., Muyldermans S., Robinson G., Hamers C., Songa E.B., Bendahman N., Hamers R. Naturally-occurring antibodies devoid of light chains. Nature 1993, 363:446-448.
31. Harmsen M.M., De Haard H.J. Properties, production and applications of camelid single-domain antibody fragments. Appl. Microbiol. Biotechnol. 2007, 77:13-22.
32. Hensley L.E., Stevens E.L., Yan B., Geisbert J.B., Macias W.L., Larsen T., Daddario-DiCaprio K.M., Cassell G.H., Jahrling P.B., Geisbert T.W. Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. JID 2007, 196:S390-S399.
33. ICTV, 2005. Virus Taxonomy - 2005. ICTV website, based on the 8th report of the ICTV edn: International Committee on Taxonomy of Viruses. http://www.ictvonline.org/.
34. Ikegami T., Niikura M., Saijo M., Miranda M.E., Calaor A.B., Hernandez M., Acosta L.P., Manalo D.L., Kurane I., Yoshikawa Y., Morikawa S. Antigen capture enzyme-linked immunosorbent assay for specific detection of Reston ebolavirus nucleoprotein. Clin. Diagn. Lab. Immunol. 2003, 10:552-557.
35. Kazachinskaia E.I., Pereboev A.V., Chepurnov A.A., Belanov E.F., Razumov I.A. Monoclonal antibodies to Ebola virus: isolation, characteristics, and study of cross reactivity with Marburg virus. Vopr. Virusol. 2000, 45:40-44.
36. Khan A.S., Tshioko F.K., Heymann D.L., Le Guenno B., Nabeth P., Kerstiens B., Fleerackers Y., Kilmarx P.H., Rodier G.R., Nkuku O., Rollin P.E., Sanchez A., Zaki S.R., Swanepoel R., Tomori O., Nichol S.T., Peters C.J., Muyembe-Tamfum J.J., Ksiazek T.G. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit. J. Infect. Dis. 1999, 179(Suppl. 1):S76-86.
37. Krebber A., Bornhauser S., Burmester J., Honegger A., Willuda J., Bosshard H.R., Pluckthun A. Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system. J. Immunol. Methods 1997, 201:35-55.
38. Ksiazek T.G., Rollin P.E., Williams A.J., Bressler D.S., Martin M.L., Swanepoel R., Burt F.J., Leman P.A., Khan A.S., Rowe A.K., Mukunu R., Sanchez A., Peters C.J. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J. Infect. Dis. 1999, 179(Suppl. 1):S177-187.
39. Ksiazek T.G., West C.P., Rollin P.E., Jahrling P.B., Peters C.J. ELISA for the detection of antibodies to Ebola viruses. J. Infect. Dis. 1999, 179(Suppl. 1):S192-198.
40. Ksiazek T.G., Rollin P.E., Jahrling P.B., Johnson E., Dalgard D.W., Peters C.J. Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J. Clin. Microbiol. 1992, 30:947-950.
41. Kudoyarova-Zubavichene N.M., Sergeyev N.N., Chepurnov A.A., Netesov S.V. Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections. J. Infect. Dis. 1999, 179(Suppl. 1):S218-S223.
42. Ladenson R.C., Crimmins D.L., Landt Y., Ladenson J.H. Isolation and characterisation of a thermally stable recombinant anti-caffine heavy chain antibody fragment. Anal. Chem. 2006, 78:4501-4508.
43. Leroy E.M., Baize S., Lu C.Y., McCormick J.B., Georges A.J., Georges-Courbot M.C., Lansoud-Soukate J., Fisher-Hoch S.P. Diagnosis of Ebola haemorrhagic fever by RT-PCR in an epidemic setting. J. Med. Virol. 2000, 60:463-467.
44. Liu J.L., Anderson G.P., Delehanty J.B., Baumann R., Hayhurst A., Goldman E.R. Selection of cholera toxin specific IgNAR V single-domain antibodies from a naïve shark library. Mol. Immunol. 2007, 44:1775-1783.
45. Liu J.L., Anderson G.P., Goldman E.R. Isolation of anti-toxin single domain antibodies from a semi-synthetic spiny dogfish shark display library. BMC Biotechnol. 2007, 7:78.
46. Lloyd E.S., Zaki S.R., Rollin P.E., Tshioko K., Bwaka M.A., Ksiazek T.G., Calain P., Shieh W.J., Konde M.K., Verchueren E., Perry H.N., Manguindula L., Kabwau J., Ndambi R., Peters C.J. Long-term disease surveillance in Bandundu region, Democratic Republic of the Congo: a model for early detection and prevention of Ebola hemorrhagic fever. J. Infect. Dis. 1999, 179(Suppl. 1):S274-S280.
47. Lucht A., Grunow R., Moller P., Feldmann H., Becker S. Development, characterization and use of monoclonal VP40-antibodies for the detection of Ebola virus. J. Virol. Methods 2003, 111:21-28.
48. Merzlikin N.V., Chepurnov A.A., Istomina N.N., Ofitserov V.I., Vorob'eva M.S. Development and application of an immunoenzyme test system for diagnosing Ebola fever. Vopr. Virusol. 1995, 40:31-35.
49. Niikura M., Ikegami T., Saijo M., Kurane I., Miranda M.E., Morikawa S. Detection of ebola viral antigen by enzyme-linked immunosorbent assay using a novel monoclonal antibody to nucleoprotein. J. Clin. Microbiol. 2001, 39:3267-3271.
50. Nissim A., Hoogenboom H.R., Tomlinson I.M., Flynn G., Midgley C., Lane D., Winter G. Antibody fragments from a " single pot" phage display library as immunological reagents. EMBO J. 1994, 13:692-698.
51. Perez J.M., Renisio J.G., Prompers J.J., van Platerink C.J., Cambillau C., Darbon H., Frenken L.G. Thermal unfolding of a llama antibody fragment: a two-state reversible process. Biochemistry 2001, 40:74-83.
52. Prehaud C., Hellebrand E., Coudrier D., Volchkov V.E., Volchkova V.A., Feldmann H., Le Guenno B., Bouloy M. Recombinant Ebola virus nucleoprotein and glycoprotein (Gabon 94 strain) provide new tools for the detection of human infections. J. Gen. Virol. 1998, 79:2565-2572.
53. Rodriguez L.L., De Roo A., Guimard Y., Trappier S.G., Sanchez A., Bressler D., Williams A.J., Rowe A.K., Bertolli J., Khan A.S., Ksiazek T.G., Peters C.J., Nichol S.T. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J. Infect. Dis. 1999, 179(Suppl. 1):S170-S176.
54. Roux K.H., Greenberg A.S., Greene L., Strelets L., Avila D., McKinney E.C., Flajnik M.F. Structural analysis of the nurse shark (new) antigen receptor (NAR): molecular convergence of NAR and unusual mammalian immunoglobulins. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:11804-11809.
55. Rowe A.K., Bertolli J., Khan A.S., Mukunu R., Muyembe-Tamfum J.J., Bressler D., Williams A.J., Peters C.J., Rodriguez L., Feldmann H., Nichol S.T., Rollin P.E., Ksiazek T.G. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit. J. Infect. Dis 1999, 179(Suppl. 1):S28-S35.
56. Saijo M., Niikura M., Morikawa S., Ksiazek T.G., Meyer R.F., Peters C.J., Kurane I. Enzyme-linked immunosorbent assays for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins. J. Clin. Microbiol. 2001, 39:1-7.
57. Sanchez A., Geisbert T.W., Feldmann H. Filoviridae: Marburg and Ebola viruses. Fields Virology 2007, 1409-1448. Lippincott Williams and Wilkins, Philadelphia. fifth ed. D. Knipe, P. Howley (Eds.).
58. Sanchez A., Khan A.S., Zaki S.R., Nabel G.J., Ksiazek T.G., Peters C.J. Filoviridae: Marburg and Ebola viruses. Fields Virology 2001, Lippincott Williams & Wilkins, Philadelphia. fourth ed. P.M. Howley (Ed.).
59. Shahhosseini S., Das D., Qiu X., Feldmann H., Jones S.M., Suresh M.R. Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens. J. Virol. Methods 2007, 143:29-37.
60. Shao C.-Y., Secombes C.J., Porter A.J. Rapid isolation of IgNAR variable single-domain antibody fragments from a shark synthetic library. Mol. Immunol. 2007, 44:656-665.
61. Sherwood L.J., Osborn L.E., Carrion R., Patterson J.L., Hayhurst A. Rapid assembly of sensitive antigen-capture assays for Marburg virus, using and in vitro selection of llama single-domain antibodies at biosafety level 4. JID 2007, 196:S213-219.
62. Suran A.A., Tarail M., Papermaster B.W. Immunoglobulins of the Leopard shark: I. Isolation and characterisation of 17S and 7S immunoglobulins with precipitating activity. J. Immunol. 1967, 99:679-686.
63. Tikunova N.V., Batanova T.A., Chepurnov A.A. Human recombinant antibodies to Ebola virus: preparation and characteristics. Vopr. Virusol. 2005, 50:25-29.
64. Towner J.S., Sealy T.K., Khristova M.L., Albarino C.G., Conlan S., Reeder S.A., Quan P.-L., Lipkin W.I., Downing R., Tappero J.W., Okware S., Lutwama J., Bakamutumaho B., Kayiwa J., Comer J.A., Rollin P.E., Ksiazek T.G., Nichol S.T. Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathogens 2008, 4:1-6.
65. Towner J.S., Rollin P.E., Bausch D.G., Sanchez A., Crary S.M., Vincent M., Lee W.F., Spiropoulou C.F., Ksiazek T.G., Lukwiya M., Kaducu F., Downing R., Nichol S.T. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J. Virol. 2004, 78:4330-4341.
66. Wesolowski J., Alzogaray V., Reyelt J., Unger M., Juarez K., Urrutia M., Cauerhff A., Danquah W., Rissiek B., Scheuplein F., Schwarz N., Adriouch S., Boyer O., Seman M., Licea A., Serreze D.V., Goldbaum F.A., Haag F., Kock-Nolte F. Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med. Microbiol. Immunol. 2009, 198:157-174.
67. WHO Ebola haemorrhagic fever in Zaire 1976 - Report of an International Commission. Bulletin of the World Health Organisation 1978, 56:271-293.
68. Wilson J.A., Hevey M., Bakken R., Guest S., Bray M., Schmaljohn A.L., Hart M.K. Epitopes involved in antibody-mediated protection from Ebola virus. Science 2000, 287:1664-1666.